Physician profile
Kyle A Schultz
NPI 1730534926
$23,937.29
in general payments reported to CMS, 2019-2025
21 companies · $1,430 in 2025
The $1,430 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $77.71 · 2021: $1,474 · 2022: $17K · 2023: $1,813 · 2024: $1,058 · 2025: $1,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,652 · Travel and Lodging: $1,011 · Education: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,651.94 |
| Travel and Lodging | $1,011.08 |
| Education | $638.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,347.65 | 2022-2023 | |
| Kairos Surgical INC | $6,299.29 | 2022 | |
| Encore Medical, LP | $2,364.12 | 2021-2022 | |
| Stryker Corporation | $1,563.63 | 2020-2025 | Gamma, Aequalis Perform+, Bio4 |
| Smith+Nephew, INC. | $1,269.57 | 2021-2023 | Journey II, Real Intelligence, K-15 Pork |
| Crossroads Orthopedics, LLC | $1,256.18 | 2022-2023 | |
| Prodigy Surgical Distribution, INC. | $1,225.08 | 2021 | |
| Pinnacle, INC | $1,144.00 | 2019-2022 | |
| Linvatec Corporation | $898.18 | 2023-2025 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Zimmer Biomet Holdings, INC. | $753.32 | 2023-2024 | Identity, Persona, Avitus Bone Harvester |
| Novus Surgical Consultants | $150.00 | 2023 | |
| Alphatec Spine, INC | $142.46 | 2025 | |
| Surgenex LLC | $132.08 | 2025 | Pellograft, Surmatrix, Renograft |
| Depuy Synthes Sales INC. | $117.96 | 2019 | |
| Medical Device Business Services, INC. | $102.55 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $77.00 | 2021 | |
| Acumed LLC | $28.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.69 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.67 | 2025 | |
| Anika Therapeutics, INC. | $15.91 | 2022 | |
| Orthofix Medical, INC. | $13.11 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.